協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/01/09 | 2,307 | 2,330 | 2,296.5 | 2,320 | +6 | +0.3% | 877,200 |
2025/01/08 | 2,331.5 | 2,337 | 2,314 | 2,314 | -17.5 | -0.8% | 778,600 |
2025/01/07 | 2,334 | 2,343 | 2,325.5 | 2,331.5 | +5 | +0.2% | 718,400 |
2025/01/06 | 2,374 | 2,385 | 2,317.5 | 2,326.5 | -49 | -2.1% | 1,077,200 |
2024/12/30 | 2,384.5 | 2,396 | 2,371 | 2,375.5 | -9 | -0.4% | 679,900 |
2024/12/27 | 2,362 | 2,391.5 | 2,360 | 2,384.5 | -4 | -0.2% | 833,300 |
2024/12/26 | 2,370 | 2,388.5 | 2,369.5 | 2,388.5 | +9 | +0.4% | 825,600 |
2024/12/25 | 2,390 | 2,393 | 2,369 | 2,379.5 | -6.5 | -0.3% | 519,100 |
2024/12/24 | 2,395 | 2,396.5 | 2,380 | 2,386 | +1.5 | +0.1% | 345,200 |
2024/12/23 | 2,390 | 2,392.5 | 2,366 | 2,384.5 | +9 | +0.4% | 465,100 |
2024/12/20 | 2,397.5 | 2,404.5 | 2,373.5 | 2,375.5 | -17 | -0.7% | 969,300 |
2024/12/19 | 2,370 | 2,401 | 2,369 | 2,392.5 | +10.5 | +0.4% | 682,300 |
2024/12/18 | 2,393 | 2,402.5 | 2,372.5 | 2,382 | -15 | -0.6% | 704,000 |
2024/12/17 | 2,385 | 2,417 | 2,385 | 2,397 | +12 | +0.5% | 1,063,200 |
2024/12/16 | 2,410 | 2,426.5 | 2,373 | 2,385 | -28 | -1.2% | 1,091,400 |
2024/12/13 | 2,433 | 2,456 | 2,413 | 2,413 | -43.5 | -1.8% | 1,341,800 |
2024/12/12 | 2,466 | 2,473 | 2,453 | 2,456.5 | -7.5 | -0.3% | 1,205,900 |
2024/12/11 | 2,491.5 | 2,501 | 2,451.5 | 2,464 | -19 | -0.8% | 1,068,700 |
2024/12/10 | 2,532 | 2,532 | 2,464 | 2,483 | -25 | -1% | 970,200 |
2024/12/09 | 2,474.5 | 2,536 | 2,474.5 | 2,508 | +50 | +2% | 1,349,400 |
2024/12/06 | 2,446 | 2,467 | 2,425.5 | 2,458 | +14.5 | +0.6% | 1,115,300 |
2024/12/05 | 2,461.5 | 2,468.5 | 2,443.5 | 2,443.5 | -1.5 | -0.1% | 1,223,400 |
2024/12/04 | 2,461 | 2,486.5 | 2,430.5 | 2,445 | -52.5 | -2.1% | 1,169,400 |
2024/12/03 | 2,479 | 2,514 | 2,467 | 2,497.5 | +19 | +0.8% | 1,171,100 |
2024/12/02 | 2,495.5 | 2,500 | 2,460.5 | 2,478.5 | -7.5 | -0.3% | 924,800 |
2024/11/29 | 2,467 | 2,502.5 | 2,466 | 2,486 | -18 | -0.7% | 721,900 |
2024/11/28 | 2,479 | 2,508.5 | 2,466 | 2,504 | +18 | +0.7% | 1,351,600 |
2024/11/27 | 2,480 | 2,506.5 | 2,469.5 | 2,486 | +16.5 | +0.7% | 946,600 |
2024/11/26 | 2,484 | 2,512 | 2,455 | 2,469.5 | -33 | -1.3% | 1,231,900 |
2024/11/25 | 2,560 | 2,560 | 2,502.5 | 2,502.5 | -20.5 | -0.8% | 2,980,400 |
2024/11/22 | 2,538 | 2,546.5 | 2,511 | 2,523 | -22 | -0.9% | 1,201,400 |
2024/11/21 | 2,600 | 2,633 | 2,543.5 | 2,545 | +17 | +0.7% | 1,858,400 |
2024/11/20 | 2,559.5 | 2,585 | 2,517 | 2,528 | -29.5 | -1.2% | 1,522,700 |
2024/11/19 | 2,593.5 | 2,598.5 | 2,557 | 2,557.5 | -15.5 | -0.6% | 982,100 |
2024/11/18 | 2,554 | 2,582 | 2,548 | 2,573 | +3 | +0.1% | 881,100 |
2024/11/15 | 2,586 | 2,600.5 | 2,570 | 2,570 | +1 | ±0% | 769,400 |
2024/11/14 | 2,584 | 2,600 | 2,564.5 | 2,569 | +1.5 | +0.1% | 780,600 |
2024/11/13 | 2,608 | 2,617.5 | 2,553.5 | 2,567.5 | -42 | -1.6% | 1,352,400 |
2024/11/12 | 2,614.5 | 2,629.5 | 2,599.5 | 2,609.5 | -15.5 | -0.6% | 817,900 |
2024/11/11 | 2,598 | 2,631.5 | 2,594.5 | 2,625 | +10.5 | +0.4% | 735,800 |
2024/11/08 | 2,635 | 2,641 | 2,591.5 | 2,614.5 | +5.5 | +0.2% | 1,122,500 |
2024/11/07 | 2,586.5 | 2,621.5 | 2,570.5 | 2,609 | +37 | +1.4% | 1,285,900 |
2024/11/06 | 2,582 | 2,619 | 2,561.5 | 2,572 | -10 | -0.4% | 1,339,000 |
2024/11/05 | 2,500 | 2,597 | 2,461 | 2,582 | +63.5 | +2.5% | 1,662,700 |
2024/11/01 | 2,475 | 2,559.5 | 2,466 | 2,518.5 | -4.5 | -0.2% | 1,735,600 |
2024/10/31 | 2,539 | 2,539 | 2,508 | 2,523 | +12.5 | +0.5% | 1,413,200 |
2024/10/30 | 2,548 | 2,555 | 2,503 | 2,510.5 | -39 | -1.5% | 1,996,700 |
2024/10/29 | 2,552 | 2,570.5 | 2,542 | 2,549.5 | -15 | -0.6% | 874,700 |
2024/10/28 | 2,524.5 | 2,581 | 2,522.5 | 2,564.5 | +32 | +1.3% | 938,000 |
2024/10/25 | 2,565 | 2,571 | 2,522.5 | 2,532.5 | -17.5 | -0.7% | 1,104,500 |
151~
200
件表示中 / 3766件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 263,600円 | -3.5% | -11.3% | 2.28% | 24.21倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 168,600円 | +0.9% | +380.2% | 4.63% | 23.23倍 | 2.00倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 261,400円 | +20.9% | +10.6% | 2.52% | 12.36倍 | 1.63倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 464,100円 | +0.1% | -3.4% | 3.45% | 31.55倍 | 1.56倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 166,300円 | +0.6% | +43.3% | 4.81% | 11.67倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム